[go: up one dir, main page]

ATE380785T1 - Herstellung eines neolignans mittels durch ddq vermittelte dimerisierung von dihydroasaron - Google Patents

Herstellung eines neolignans mittels durch ddq vermittelte dimerisierung von dihydroasaron

Info

Publication number
ATE380785T1
ATE380785T1 AT02713168T AT02713168T ATE380785T1 AT E380785 T1 ATE380785 T1 AT E380785T1 AT 02713168 T AT02713168 T AT 02713168T AT 02713168 T AT02713168 T AT 02713168T AT E380785 T1 ATE380785 T1 AT E380785T1
Authority
AT
Austria
Prior art keywords
neolignan
ddq
preparation
asarone
dihydroasarone
Prior art date
Application number
AT02713168T
Other languages
English (en)
Inventor
Arun Kumar Sinha
B P Joshi
Ruchi Acharya
Original Assignee
Council Scient Ind Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Council Scient Ind Res filed Critical Council Scient Ind Res
Application granted granted Critical
Publication of ATE380785T1 publication Critical patent/ATE380785T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/205—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring the aromatic ring being a non-condensed ring
    • C07C43/2055—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring the aromatic ring being a non-condensed ring containing more than one ether bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/215—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring having unsaturation outside the six-membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AT02713168T 2002-03-27 2002-03-27 Herstellung eines neolignans mittels durch ddq vermittelte dimerisierung von dihydroasaron ATE380785T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/IN2002/000073 WO2003080551A1 (en) 2002-03-27 2002-03-27 Formation of neolignan by ddq mediated dimerisation of dihydroasarone
US10/108,269 US20030187306A1 (en) 2002-03-27 2002-03-28 DDQ mediated one step dimerisation of beta-asarone or beta-asarone rich acorus calamus oil in the formation of novel neolignan

Publications (1)

Publication Number Publication Date
ATE380785T1 true ATE380785T1 (de) 2007-12-15

Family

ID=30002057

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02713168T ATE380785T1 (de) 2002-03-27 2002-03-27 Herstellung eines neolignans mittels durch ddq vermittelte dimerisierung von dihydroasaron

Country Status (7)

Country Link
US (2) US20030187306A1 (de)
EP (1) EP1487770B1 (de)
JP (1) JP4266348B2 (de)
AT (1) ATE380785T1 (de)
AU (1) AU2002244906A1 (de)
DE (1) DE60224098T2 (de)
WO (1) WO2003080551A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1577289A1 (de) * 2004-03-18 2005-09-21 Revotar Biopharmaceuticals AG Nicht-glykosylierte/-glykosidische/-peptidische keine Moleküle als Selektininhibitoren für die Behandlung entzündlicher Erkrankungen.
EP1764094A1 (de) * 2005-09-20 2007-03-21 Revotar Biopharmaceuticals AG Neuartige multi-zyklische Verbindungen und deren Verwendung
EP1764095A1 (de) * 2005-09-20 2007-03-21 Revotar Biopharmaceuticals AG Neue Nitrocatecholderivate mit Selectin-Ligand-Activität
EP1764093A1 (de) * 2005-09-20 2007-03-21 Revotar Biopharmaceuticals AG Neue aromatische Verbindungen und deren medizinische Verwendung
EP1764096A1 (de) * 2005-09-20 2007-03-21 Revotar Biopharmaceuticals AG Neue Phloroglucinolderivate mit Selectin-Ligand-Aktivität
JP4977032B2 (ja) 2005-10-13 2012-07-18 山本化成株式会社 スルホ基を含有する高分子化合物、および該化合物を含有する有機電界発光素子
US8049326B2 (en) * 2007-06-07 2011-11-01 The Regents Of The University Of Michigan Environment-resistant module, micropackage and methods of manufacturing same
US7872160B2 (en) * 2008-03-31 2011-01-18 Council Of Scientific & Industrial Research Single pot process for the regioselective synthesis of neolignan framework asarones
JP5673026B2 (ja) * 2010-11-26 2015-02-18 ユーハ味覚糖株式会社 ４−ビニルグアイアコール重合化合物又はその薬学的に許容可能な塩を含む抗癌剤、食品、医薬品
JP5673030B2 (ja) * 2010-11-29 2015-02-18 ユーハ味覚糖株式会社 新規フェノール性２量体化合物
CN102126933B (zh) * 2010-12-20 2013-03-20 湖南大学 一种二苯基丙烷类木脂素化合物及其制备方法
CN106860437B (zh) * 2017-02-21 2019-08-02 南方医科大学 双细辛酮i作为治疗登革病毒感染的药物及其制药用途
CN116554397A (zh) * 2023-05-18 2023-08-08 深圳市德泰能源有限公司 一种锂电池负极粘结剂及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3769350A (en) 1968-12-09 1973-10-30 Hoffmann La Roche Method for making 2,3-dimethyl-1,4-bis(3,4 - hydrocarbonyloxyphenyl) - 1,4-butanedione
US4540709A (en) 1983-10-13 1985-09-10 Merck & Co., Inc. Method for treatment of diseases mediated by PAF using 5-allyl-2-(3,4-Dimethoxyphenyl)-3a,α-methoxy-3-methyl-2,3,3a,6-tetrahydro-6-oxobenzofuran
FR2595350B1 (fr) 1986-03-06 1988-11-10 Maine Universite Procede de couplage biarylique, catalyseur au ruthenium pour sa mise en oeuvre et nouveaux composes en resultant
US5639782A (en) 1992-03-04 1997-06-17 Center For Innovative Technology Neolignan derivatives as platelet activating factor receptor antagonists and 5-lipoxygenase inhibitors
US6136992A (en) 1997-03-13 2000-10-24 The United States Of America As Represented By The Department Of Health And Human Services 2-alkoxy estradiols and derivatives thereof
US6590127B1 (en) * 2002-03-28 2003-07-08 Council Of Scientific & Industrial Research Process for the preparation of pharmacologically active α-asarone from toxic β-asarone rich acorus calamus oil

Also Published As

Publication number Publication date
AU2002244906A1 (en) 2003-10-08
DE60224098T2 (de) 2008-12-04
JP4266348B2 (ja) 2009-05-20
DE60224098D1 (de) 2008-01-24
US20030187306A1 (en) 2003-10-02
WO2003080551A1 (en) 2003-10-02
EP1487770B1 (de) 2007-12-12
JP2005521734A (ja) 2005-07-21
EP1487770A1 (de) 2004-12-22
US6969778B2 (en) 2005-11-29
US20040049085A1 (en) 2004-03-11

Similar Documents

Publication Publication Date Title
ATE380785T1 (de) Herstellung eines neolignans mittels durch ddq vermittelte dimerisierung von dihydroasaron
EA200201056A1 (ru) Новые, обладающие продолжительным действием бетамиметики, способ их получения и их применение в качестве лекарственных средств
AR064833A1 (es) Un procedimiento para la preparacion de vildagliptin
TWI365867B (en) Process for preparing cyclohexanone and cyclohexanol
DE60332776D1 (de) Herstellung von Delta-9-Tetrahydrocannabinol
AR041587A1 (es) Proceso para la preparacion de (s,s)-cis-2-benzhidril-3- benzilaminoquinuclidina
BR0108063A (pt) Processo para epoxidação de olefinas
NO20060109L (no) Fremgangsmate for fremstilling av alfa- 1antitrypsinlosning
WO2007004092A3 (en) Novel intermediates, process for their preparation and process for the preparation of coq10 employing the said novel intermediates
Freedman Tetraphenylcyclobutadiene Derivatives. I. Tetraphenylcyclobutadiene Nickel Bromide Complex
GB2373743B (en) Solvent exchange process
GB2437006A (en) Salts assisted selective extraction of 6-acetyl-4.1',6'trichlorogalactosucrose and 4,1',6'trichlorogalactosucrose from aqueous reaction mixture
DE60134472D1 (de) Oxidationsverfahren zur herstellung des zwischenproduktes 6.alpha.,9.alpha.-difluoro-11.beta.,17.alpone 17.beta.-karbonsäure
BR0206531A (pt) Processos para a recuperação de uma composição enriquecida em componentes tetramantano e outros componentes diamantóides superiores, e de uma composição enriquecida em componentes tetramantano e pentamantano, composição compreendendo pelo menos componentes tetramantano e pentamantano, processo, e, processos para a recuperação do componente ou componentes diamantóides superiores selecionados, de uma composição enriquecida em um ou mais destes componentes, e de pelo menos um diamantóide superior selecionado
ATE442355T1 (de) Herstellung von 4,5-dialkyl-3-acylpyrrol-2- carbonsäurederivaten durch synthese nach fischer- fink und anschliebende acylierung
ECSP045222A (es) INHIBIDORES DE LA ADHESION CELULAR MEDIADA POR INTEGRINA aLb2
ATE427934T1 (de) Nicht-peptidische brs-3-agonisten
JPS6445404A (en) Production of hydrogenated nitrile rubber
AR046093A1 (es) Procedimeinto para preparar un compuesto de azabiciclo [ 3,1,0 ] hexano
DE60325731D1 (en) Monopropylenglykol als fermentationszusatz
AP1511A (en) Process for the isolation of crystalline imipenem.
NO20043551L (no) To gonadotropinfrigjorende hormoner og en fremgangsmate til a isolere dem
DE60328915D1 (de) Verfahren zur herstellung von dem bicyclischen hexapeptide nepadutant
NZ544481A (en) norgestrel 3e- and -3z-oxime isomers, as well as process for the synthesis of the mixture of isomers and the pure isomers
GB2418916A (en) Process for purifying citalopram using polybasic acids

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties